Advanced Care Scripts News Today

The U.S. District Court for the District of Massachusetts recently weighed in on the burgeoning court split in False Claims Act (FCA) cases, adopting an approach that puts a higher...

Where a plaintiff insurance company has filed a complaint under the Racketeer Influenced and Corrupt Organizations statute alleging that the defendant made unlawful charitable donations to fund patient copays of its multiple sclerosis drugs, the defendant’s motion to dismiss should be allowed because the plaintiff is an indirect purchaser of the pharmaceutical products at issue,

CANTON — St. Lawrence University’s Alumni Executive Council has announced that Dr. William A. Van Wie ‘67, Barbarajean “BJ” Schaefer Blodgett ‘72, Jeffrey P. Spafford ‘88, and Dr. Wambui Mutoru

ADVERTISEMENT ADVERTISEMENT Teva, Pharmacies Want Humanas Copay Fraud Claims Tossed Law360 (April 5, 2021, 7:43 PM EDT) -- Teva Pharmaceuticals and two specialty pharmacies have slammed a lawsuit from Humana accusing them of conspiring to bilk Medicare and private insurers through copayment assistance for the multiple sclerosis drug Copaxone, saying the insurer openly knew the facts surrounding the alleged scheme and waited too long to sue. Teva Pharmaceuticals USA Inc. and Teva Neuroscience I...

Biogen To Pay $22 Million To Settle DOJ Claims Alleging Copay Scheme What’s New/Significant The U.S. Department of Justice reached a $22 million settlement with Biogen Inc. on Dec. 17 to end allegations that the pharmaceutical company violated the False Claims Act (FCA) by paying through two foundations the copays of Medicare patients taking Avonex and Tysabri, Biogen’s drugs to treat multiple sclerosis. The settlement resolves a whistleblower lawsuit filed under the FCA. The whistleblower ...

Biogen Agrees To Pay $22 Mln To Settle Kickback Allegations WESTON (dpa-AFX) - Biogen has agreed to pay $22 million to settle allegations that it illegally using foundations as a conduit to pay the copays of Medicare patients taking the companys multiple sclerosis drugs, the U.S. Justice Department said. Advanced Care Scripts, a pharmacy company that worked with Biogen, agreed to pay $1.4 million to settle the allegation. The whistleblower will receive about $3.96 million of the settlement, th...

The Biogen pharmaceutical company on Thursday agreed to pay $22 million to resolve allegations that it illegally paid insurance co-payments for thousands of patients in order to collect Medicare revenue, federal prosecutors said. The company was accused of channeling money through two nonprofit foundations to cover co-payments for patients who were using Biogen drugs used to treat multiple sclerosis. Prosecutors said Biogen identified patients who were in its free drug program for low-income pa...

December 17, 2020 BOSTON (AP) — The Biogen pharmaceutical company on Thursday agreed to pay $22 million to resolve allegations that it illegally paid insurance co-payments for thousands of patients in order to collect Medicare revenue, federal prosecutors said. The company was accused of channeling money through two nonprofit foundations to cover co-payments for patients who were using Biogen drugs used to treat multiple sclerosis. Prosecutors said Biogen identified patients who were in its f...

ADVERTISEMENT ADVERTISEMENT Biogen To Pay $22M To Resolve Drug Kickback Claims Law360 (December 17, 2020, 4:29 PM EST) -- Biogen Inc. will pay $22 million to resolve allegations that it illegally used two foundations to pay Medicare co-pays for patients taking the companys multiple sclerosis drugs, becoming the latest in a line of pharmaceutical companies to settle kickback claims. Announcing the civil settlement Thursday, the Boston U.S. attorneys office alleged Biogen ran afoul of the False...

Pharma Giant And Speciality Pharmacy Settle Case Alleging False Claims Violations News provided by Share this article Share this article BOSTON, Dec. 17, 2020 /PRNewswire/ -- One of the worlds largest pharmaceutical companies, Biogen, Inc., and a large specialty pharmacy, Advanced Care Scripts, Inc. (ACS), will pay a combined $23.4 million to settle allegations under the Federal False Claims Act that kickbacks were used to induce the sale of drugs used to treat multiple sclerosis. Biogen will p...